Prosecutor's Appeal Suspends ABL Diagnostics' Acquisition of IntegraGen Assets

ABL Diagnostics' acquisition of IntegraGen's assets and operations is suspended following an appeal by the public prosecutor in Évry-Courcouronnes. The appeal challenges the Évry-Courcouronnes commercial court's October 9, 2026, ruling selecting its takeover offer. IntegraGen has returned to judicial reorganization pending a decision by the Paris Court of Appeal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via (Ref. ID: 20261016167707) on October 16, 2026, and is solely responsible for the information contained therein. (C)